DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,303,462 | +4.4% | 17,346 | +1.0% | 0.16% | -4.3% |
| Q2 2023 | $4,121,788 | -70.3% | 17,174 | -68.8% | 0.16% | -72.2% |
| Q1 2023 | $13,871,054 | +166.9% | 55,035 | +181.0% | 0.58% | +157.5% |
| Q4 2022 | $5,197,876 | -52.6% | 19,584 | -53.9% | 0.23% | -56.5% |
| Q3 2022 | $10,963,000 | -16.5% | 42,444 | -18.0% | 0.52% | -17.2% |
| Q2 2022 | $13,127,000 | -34.8% | 51,779 | -15.4% | 0.63% | -25.1% |
| Q4 2021 | $20,139,000 | +13.2% | 61,208 | +4.8% | 0.84% | -0.6% |
| Q3 2021 | $17,785,000 | +16.2% | 58,419 | +3.9% | 0.84% | +11.5% |
| Q2 2021 | $15,301,000 | +48.4% | 56,212 | +22.7% | 0.76% | +29.0% |
| Q1 2021 | $10,309,000 | +28.8% | 45,801 | +26.8% | 0.59% | +1.2% |
| Q4 2020 | $8,001,000 | +36.9% | 36,117 | +33.1% | 0.58% | +10.7% |
| Q3 2020 | $5,845,000 | +95.7% | 27,145 | +60.8% | 0.52% | +74.9% |
| Q2 2020 | $2,986,000 | +46.7% | 16,886 | +14.8% | 0.30% | +8.7% |
| Q1 2020 | $2,035,000 | +90.7% | 14,706 | +111.6% | 0.28% | +105.2% |
| Q4 2019 | $1,067,000 | +65.9% | 6,950 | +56.1% | 0.13% | +32.7% |
| Q3 2019 | $643,000 | +3.7% | 4,452 | +2.7% | 0.10% | -2.9% |
| Q2 2019 | $620,000 | +16.3% | 4,336 | +7.4% | 0.10% | +28.4% |
| Q1 2019 | $533,000 | +40.6% | 4,038 | +9.8% | 0.08% | -2.4% |
| Q4 2018 | $379,000 | – | 3,677 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |